<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">23342114</PMID>
        <DateCompleted>
            <Year>2013</Year>
            <Month>08</Month>
            <Day>02</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>8</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2013</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Irradiated riboflavin diminishes the aggressiveness of melanoma in vitro and in vivo.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e54269</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0054269</ELocationID>
            <Abstract>
                <AbstractText>Melanoma is one of the most aggressive skin cancers due to its high capacity to metastasize. Treatment of metastatic melanomas is challenging for clinicians, as most therapeutic agents have failed to demonstrate improved survival. Thus, new candidates with antimetastatic activity are much needed. Riboavin (RF) is a component of the vitamin B complex and a potent photosensitizer. Previously, our group showed that the RF photoproducts (iRF) have potential as an antitumoral agent. Hence, we investigated the capacity of iRF on modulating melanoma B16F10 cells aggressiveness in vitro and in vivo. iRF decreases B16F10 cells survival by inhibiting mTOR as well as Src kinase. Moreover, melanoma cell migration was disrupted after treatment with iRF, mainly by inhibition of metalloproteinase (MMP) activity and expression, and by increasing TIMP expression. Interestingly, we observed that the Hedgehog (HH) pathway was inhibited by iRF. Two mediators of HH signaling, GLI1 and PTCH, were downregulated, while SUFU expression (an inhibitor of this cascade) was enhanced. Furthermore, inhibition of HH pathway signaling by cyclopamine and Gant 61 potentiated the antiproliferative action of RF. Accordingly, when a HH ligand was applied, the effect of iRF was almost completely abrogated. Our findings indicate that Hedgehog pathway is involved on the modulation of melanoma cell aggressiveness by iRF. Moreover, iRF treatment decreased pulmonary tumor formation in a murine experimental metastasis model. Research to clarify the molecular action of flavins, in vivo, is currently in progress. Taken together, the present data provides evidence that riboflavin photoproducts may provide potential candidates for improving the efficiency of melanoma treatment.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Machado</LastName>
                    <ForeName>Daisy</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Bioassays and Signal Transduction, Department of Biochemistry, Institute of Biology, University of Campinas, Campinas, SÃ£o Paulo, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shishido</LastName>
                    <ForeName>Silvia M</ForeName>
                    <Initials>SM</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Queiroz</LastName>
                    <ForeName>Karla C S</ForeName>
                    <Initials>KC</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Oliveira</LastName>
                    <ForeName>Diogo N</ForeName>
                    <Initials>DN</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Faria</LastName>
                    <ForeName>Ana L C</ForeName>
                    <Initials>AL</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Catharino</LastName>
                    <ForeName>Rodrigo R</ForeName>
                    <Initials>RR</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Spek</LastName>
                    <ForeName>C Arnold</ForeName>
                    <Initials>CA</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ferreira</LastName>
                    <ForeName>Carmen V</ForeName>
                    <Initials>CV</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2013</Year>
                <Month>01</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D005415">Flavins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C551027">GANT 61</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D011725">Pyridines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D011743">Pyrimidines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014704">Veratrum Alkaloids</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>TLM2976OFR</RegistryNumber>
                <NameOfSubstance UI="D012256">Riboflavin</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>ZH658AJ192</RegistryNumber>
                <NameOfSubstance UI="C000541">cyclopamine</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002465" MajorTopicYN="N">Cell Movement</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005415" MajorTopicYN="N">Flavins</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015603" MajorTopicYN="N">Keratinocytes</DescriptorName>
                <QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008545" MajorTopicYN="N">Melanoma</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011725" MajorTopicYN="N">Pyridines</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012256" MajorTopicYN="N">Riboflavin</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014704" MajorTopicYN="N">Veratrum Alkaloids</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2012</Year>
                <Month>08</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2012</Year>
                <Month>12</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2013</Year>
                <Month>1</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2013</Year>
                <Month>1</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2013</Year>
                <Month>8</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">23342114</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0054269</ArticleId>
            <ArticleId IdType="pii">PONE-D-12-24357</ArticleId>
            <ArticleId IdType="pmc">PMC3546980</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Exp Clin Cancer Res. 2009;28:152</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20003385</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Cancer. 2009 Apr;9(4):239-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19279573</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Invest Dermatol. 2000 Sep;115(3):337-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10951266</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am Fam Physician. 2000 Jul 15;62(2):357-68, 375-6, 381-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10929700</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 1983 May 10;258(9):5623-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6857762</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncogene. 2013 Jan 3;32(1):86-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22310287</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2011 Mar 25;331(6024):1559-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21436443</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>CA Cancer J Clin. 2012 Jul-Aug;62(4):220-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22700443</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 2009 Aug 27;114(9):1968-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19571314</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2009 Nov 1;27(31):5287-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19738110</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cell Physiol. 2011 Apr;226(4):1118-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20857406</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Physiol Rev. 2007 Oct;87(4):1343-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17928586</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Toxicol In Vitro. 2010 Oct;24(7):1911-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20688149</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Pharm. 2004 Aug 6;280(1-2):199-208</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15265559</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Dermatol. 2012 Apr;39(4):339-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22150440</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2004 Jun 18;304(5678):1755-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15205520</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cataract Refract Surg. 2007 Mar;33(3):516-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17321404</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2002 Feb 15;277(7):5548-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11719506</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dev Cell. 2006 Feb;10(2):187-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16459298</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatol Res. 2009 Feb;39(2):177-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19208038</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2004 Oct 1;64(19):7002-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15466193</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):5895-900</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17392427</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dent Mater. 2000 Mar;16(2):103-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11203530</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Biosci. 2005;10:2986-3001</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15970553</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2007 Mar 1;67(5):2187-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17332349</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>FEBS Lett. 2005 Oct 10;579(24):5361-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16198354</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cell Biol. 2010 Oct 18;191(2):415-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20956384</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2012 May 3;485(7396):55-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22367541</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Apoptosis. 2006 Oct;11(10):1761-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16927017</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dev Biol. 2009 Jun 15;330(2):452-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19371734</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Nutr. 1987 Mar;117(3):468-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3572560</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Oncol. 2012;2012:647684</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22792102</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cell Biol. 1999 Oct 4;147(1):71-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10508856</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Carcinogenesis. 2009 Jan;30(1):131-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19028702</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Lett. 2007 Dec 8;258(1):126-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17933458</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Rapid Commun Mass Spectrom. 2008 Oct;22(19):3015-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18763271</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol Methods. 1983 Dec 16;65(1-2):55-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6606682</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Actas Dermosifiliogr. 2012 Sep;103(7):579-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22261672</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Exp Cell Res. 2012 Oct 1;318(16):1959-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22659135</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cardiovasc Res. 2006 Feb 15;69(3):562-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16405877</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cell Mol Med. 2008 Dec;12(6B):2622-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18363839</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Oncol. 2011 Oct 13;1(34):null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22268005</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Cell. 2007 Jul;12(1):9-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17613433</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Cancer Biol. 2004 Feb;14(1):63-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14757536</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Oncol. 2010 Oct;37(4):1023-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20811725</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Ophthalmol. 2011 Aug;31(4):309-19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21847678</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2001 Jun;7(6):706-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11385508</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Transfus Med Rev. 2008 Apr;22(2):133-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18353253</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Opin Cell Biol. 2005 Dec;17(6):596-603</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16226444</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Soc Trans. 2000;28(4):283-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10961912</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Discov Med. 2012 Feb;13(69):105-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22369969</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Exp Biol Med (Maywood). 2007 Oct;232(9):1121-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17895520</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Sci. 2011 Feb;102(2):373-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21091847</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Genet. 2000 Mar;24(3):216-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10700170</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Signal. 2007 Dec;19(12):2596-604</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17884337</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Cancer. 2003 Jun;3(6):453-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12778135</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Cancer Res. 2012;2(2):178-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22485197</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Cutan Med Surg. 2010 Dec;29(4):249-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21277538</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncogene. 2006 Nov 9;25(53):7029-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16715128</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2009 Aug 21;284(34):22888-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19556240</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thromb Haemost. 2008 Apr;99(4):787-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18392341</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Pathol. 2008 Feb;172(2):309-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18202198</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Protein Pept Sci. 2011 Feb;12(1):30-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21190521</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>